What is myNewborn Advanced Health Screening?

myNewborn entails an expansion of the conventional neonatal biochemical screening test, increasing the metabolic and genetic diseases detected (nearly 400), which allows nutritional intervention and other procedures during the childhood, improving the newborn’s health. myNewborn is key to personalized medical management from day one.

A detailed close up view of a DNA Strand.

What Are Genomics?

A genome is an organism's complete set of DNA instructions found in a cell. It includes all of its genes as well as its hierarchical, three-dimensional structural configuration. 


In humans, the genome consists of 23 pairs of chromosomes located in the cell's nucleus. A genome contains all the information needed for an individual to develop and function.

Learn More
A scientist holding a pipette and dispensing liquid to another container.

What Do You Test For?

We analyze over 400 genes related with childhood onset genetic and metabolic diseases, adult onset diseases that are actionable during childhood, and common, although not treatable, diseases with carrier frequency higher than 1/100. Screening includes diabetes, early cardiovascular disease, certain food allergies, Usher syndrome, malignant hyperthermia, cystic fibrosis, and more.
Learn More

Why is Genomic Screening for Newborns Important?

myNewborn is a genetic screening test that analyzes the newborn's DNA through Whole Exome Sequencing (WES) to determine the presence of pathogenic variants related with actionable childhood onset diseases, allowing the specialist to improve medical care. Knowing this risk allows the implementation of appropriate monitoring or treatment in each case before the symptoms appear.

Learn More
A newborn girl peacefully sleeping, swaddled in a vibrant rainbow blanket

What Can I Expect to Receive with myNewborn Screening?

All families will receive a comprehensive report with detailed information about the variants detected and the implications for the newborn. Families will have access to a trusted genetic counselor who will interpret and discuss the results. Pathogenic variants and probably pathogenic variants classified based on American College of Medical Genetics and Genomics (ACMG) (PMID: 25741868) guidelines are reported.

A detailed pie chart consisting of different vibrant colors.

Questions About myNewborn

myNewborn Advanced Health Screening is a cutting-edge comprehensive newborn genetic prevention test that sequences a baby’s DNA to identify any genetic variations or mutations that may be associated with a range of health conditions (nearly 400 metabolic and genetic diseases). This type of testing can provide parents with valuable information about their child’s health and well-being, and can help healthcare providers diagnose and treat any illnesses that are found.

A growing number of parents opt to sequence their baby's genome, seeking insights into their child's potential risks for early-onset genetic diseases. myNewborn Advanced Health Screening represents an evolution in routine neonatal biochemical screening, significantly expanding the scope of metabolic and genetic diseases examined. This comprehensive analysis enables early intervention through tailored nutrition and other targeted procedures, ultimately enhancing the overall health and well-being of your newborn.

The Newborn Heel Prick Test and myNewborn Health Screening both play vital roles in assessing a baby's health, but they differ in several key aspects. The Newborn Heel Prick Test, a longstanding standard, screens for approximately 30 specific metabolic disorders that can significantly impact a child's well-being. It is performed in the hospital or at home within the first few days of life, enabling early detection and intervention for these conditions.

On the other hand, myNewborn Health Screening is an advanced genomic test offered by Americord, offering a more comprehensive analysis by screening for nearly 400 metabolic and genetic diseases. Using a simple saliva sample, it examines a broader spectrum of health conditions, including inherited diseases, cancers, and metabolic disorders. Moreover, myNewborn Health Screening can be conducted up to 36 months after birth, allowing parents to make informed decisions about their child's care and future.

myNewborn Advanced Health Screening utilizes whole exome sequencing to screen for more than 390 metabolic and genetic conditions that may present in early childhood. This includes diabetes, cardiovascular disease, food allergies, Usher syndrome, malignant hyperthermia, cystic fibrosis, and many more. By analyzing 407 genes associated with these conditions, myNewborn provides comprehensive insights that can help parents take proactive steps to ensure their child's health and wellbeing from the very beginning.

Newborn genomic screening is crucial for identifying potential risks and ensuring proactive healthcare management. myNewborn Advanced Health Screening is a comprehensive genetic screening test that uses Whole Exome Sequencing (WES) to analyze a newborn's DNA for pathogenic variants related to actionable childhood-onset diseases.

Early detection of these variants enables healthcare providers to develop personalized monitoring and treatment plans, ultimately improving outcomes for newborns and children. With myNewborn, you can take a proactive approach to your child's health, ensuring they receive the care and support they need to thrive.

The entire process from receiving your sample, analyzing the information, and producing your newborn's results takes up to 8 weeks. The estimated delivery time varies because every person’s genomic information is unique and may require different degrees of analysis.